Stay updated on Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial

Sign up to get notified when there's something new on the Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added a centralized Locations section listing Arizona, California, Colorado, Georgia, New York, Pennsylvania, Tennessee, and Texas, and updated the revision to v3.3.3. Removed individual per-state location links and the HHS Vulnerability Disclosure.
    Difference
    0.9%
    Check dated 2025-12-23T21:06:47.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    Publications section saw minor wording changes: new sentences clarify voluntary publication notes and auto-fill from PubMed, and the revision tag was updated to v3.3.2 (replacing v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T13:51:23.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The government funding lapse notice banner was removed from the page; this banner previously provided general operating status information but does not affect the study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T07:21:12.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    No significant changes to the study page content are observable between the screenshots; only minor formatting/layout differences are present. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:25:50.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T07:53:49.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.
    Difference
    0.0%
    Check dated 2025-09-29T04:13:14.000Z thumbnail image

Stay in the know with updates to Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial page.